Best For Patients who have plateaued on semaglutide or tirzepatide Patients with significant weight to lose (50+ pounds) Patients with fatty liver disease (MASLD/NAFLD) or metabolic syndrome Patients who want access to the most advanced mechanism currently available Patients with established GLP-1 experience and good tolerance Side Effect Comparison All three medications share a similar side effect profile driven primarily by gastrointestinal effects: Common Side Effects (All Three) Nausea most common during dose escalation, usually resolves within 2 to 4 weeks at each dose level Diarrhea reported by 15 to 25 percent of patients Vomiting reported by 8 to 15 percent Constipation reported by 6 to 12 percent Decreased appetite nearly universal and considered therapeutic Tirzepatide and retatrutide may have slightly higher rates of GI side effects than semaglutide due to the additional pathway activation
Beyond delayed emptying, individual susceptibility, the speed of dose escalation, concurrent medications, and pre-existing GI disorders influence nausea severity
Always check your vial label and use the formula: units = (dose mg / concentration mg per mL) x 100
Once prescribed by one of Get Slimss network of licensed healthcare professionals, compounded semaglutide is self-injected just once a week
The SURMOUNT-4 trial data showed that patients who stopped tirzepatide regained an average of 14% of their body weight over the following year, which is a real and significant concern for women who worked hard to lose weight before pregnancy
Tirzepatides ability to assist in weight loss stems from its multifaceted mechanism of action, targeting different regulatory hormones involved in metabolism
